Wed.Feb 10, 2021

article thumbnail

AbbVie exploring how CRISPR gene editing can improve cell therapies

Bio Pharma Dive

Using technology from Caribou Biosciences, AbbVie hopes to engineer "off-the-shelf" CAR-T cells that can better withstand attacks from the immune system.

article thumbnail

Let your agency do what they do best

World of DTC Marketing

SUMMARY: There are some excellent digital agencies dedicated to pharma. Greater-Than-One and InTouch Solutions are just a couple. Agencies have experience in leading and developing cutting-edge digital pharma marketing solutions, but they need your help to really be effective. Agencies should never be considered vendors; they are your marketing partners.

Branding 180
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA clears Lilly's COVID-19 antibody cocktail for emergency use

Bio Pharma Dive

In a late-stage study of people recently diagnosed with COVID-19, the dual-antibody drug sharply reduced the risk of hospitalizations and death.

Antibody 300
article thumbnail

How PK Modeling Can Inform Sample Size Estimation and Dose Selection for Your Product

Camargo

Drug development is an extremely cumbersome process, requiring the testing of an agent from in vitro studies to in vivo studies to in silico modeling. Given that it can take up to 20 years for a final product to be approved, it is unsurprising that drug attrition rates are very high. Pharmacokinetics (PK) and bioequivalence (BE) studies serve as the foundation of determining the fate of drug products.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

FDA advisers recommend agency wait on Keytruda approval in tough-to-treat breast cancer

Bio Pharma Dive

More data are needed to support use of the immunotherapy before surgery in triple-negative breast cancer, according to the FDA advisory committee.

161
161
article thumbnail

First look inside BioNTech's Marburg site as it starts production for COVID-19 vaccine

BioPharma Reporter

BioNTech announced this morning it has started the production of mRNA at its new facility in Marburg, Germany: which will become one of the largest mRNA manufacturing sites in Europe.

More Trending

article thumbnail

France ramps up COVID-19 vaccine production

BioPharma Reporter

Three COVID-19 vaccine manufacturing sites are set to start production in France in the coming weeks: while the French government is seeking to boost further production with a â300m ($363m) initiative announced on Monday.

article thumbnail

Triple Negative Breast Cancer Drug Development Digital Summit

pharmaphorum

Improving the Safety, Efficacy & Predictability of Monotherapy & Combinatorial Therapies to Fast-track the Discovery & Development of TNBC Treatments to Reach Patients in Need. This is the primary industry platform specifically dedicated to providing you insight into the latest developments of safe and efficacious blockbuster therapies to treat triple negative breast cancer.

article thumbnail

Synairgen’s inhaled COVID-19 treatment included in US trial

Pharma Times

Trial is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID)

Trials 152
article thumbnail

Stay calm and carry on: How to implement the updated ABPI code

pharmaphorum

Don’t panic – that’s the message from one ABPI code expert who tells Amanda Barrell it’s time to take stock and prioritise. Compliance managers have less than six months to rewrite processes and procedures in line with the updated ABPI code of practice before it becomes enforceable in July. But it doesn’t all have to be done at once, says Dr Rina Newton, managing director at code consultancy firm, CompliMed.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Semaglutide Brings Significant Weight Loss in Obese Patients

NY Times

In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.

article thumbnail

Study: Exhaled COVID-19 Aerosol Droplets Dictated by Age, Infection and Body Mass Index

BioSpace

An observational study published in the Proceedings of the National Academy of Sciences suggests there is a strong positive association between the number of coronavirus disease 2019 (COVID-19) aerosol droplets an individual breathes out with age, infection and body weight.

98
article thumbnail

Heat Bio’s shares ignite on Opdivo combination data in NSCLC

pharmaphorum

The pairing of Heat Biologics’ lead drug HS-110 with Bristol-Myers Squibb’s blockbuster checkpoint inhibitor Opdivo has boosted survival in patients with non-small cell lung cancer (NSCLC), sending the biotech’s share price skywards. . Interim data from a phase 2 trial of Heat’s off-the-shelf cell therapy with Opdivo (nivolumab) showed that patients treated with the duo as a second-line therapy had a survival benefit, particularly in patients who hadn’t previously had checkpoint inhibitor therap

article thumbnail

AstraZeneca Touts Profits While Slashing Programs

BioSpace

In the waning weeks of the fourth quarter of the 2020 fiscal year, AstraZeneca terminated several clinical programs, including some oncology and heart-related studies, as well as one COVID-19 related trial.

Trials 98
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

COVID-infected mothers separated from their babies affects breastfeeding outcomes

Scienmag

Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, February 10, 2021–It may be safe for COVID-infected mothers to maintain contact with their babies. Keeping them apart can cause maternal distress and have a negative effect on exclusive breastfeeding later in infancy, according to The COVID Mothers Study published in the peer-reviewed journal Breastfeeding Medicine. […].

article thumbnail

Signifier Medical Technologies’ Sleep Apnea Treatment Device Gets FDA Nod

XTalks

The US Food and Drug Administration (FDA) has granted marketing authorization to Signifier Medical Technologies ’ sleep apnea treatment device, called eXciteOSA. The new device is designed to reduce snoring and treat mild obstructive sleep apnea (OSA) in individuals 18 years and older, and is available by prescription only. Getting a restful night’s sleep is important for maintaining good physical and mental health.

article thumbnail

NASA’s first mission to the trojan asteroids installs its final scientific instrument

Scienmag

Credit: NASA/Goddard/Barbara Lambert/Desiree Stover With less than a year to launch, NASA’s Lucy mission’s third and final scientific instrument has been integrated onto the spacecraft. The spacecraft, which will be the first to explore the Trojan asteroids—a population of small bodies that share an orbit with Jupiter—is in the final stages of the assembly process. […].

98
article thumbnail

A study to avoid chemotherapy in patients with early HER-2+ breast cancer

pharmaphorum

MEDSIR , a global company dedicated to independent clinical research in oncology, has initiated the PHERGain II clinical trial to demonstrate that in patients with HER2-positive early breast cancer with a good prognosis, a chemotherapy-free therapeutic approach can be as effective as the current standard of care, which involves the use of this generally more toxic treatment.

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Origami powered by light

Scienmag

Pitt and CMU researchers develop high-torque light-powered actuator Credit: Mahnoush Babaei If you watch the leaves of a plant long enough, you may see them shift and turn toward the sunlight through the day. It happens slowly, but surely. Some man-made materials can mimic this slow but steady reaction to light energy, usually triggered by […].

article thumbnail

3rd Microbiome Movement – Maternal & Infant Health Summit

pharmaphorum

Harness the Maternal-Infant Microbiome, Establish New Mechanisms of Action, and Develop Breakthrough Health Products that Proactively Prevent Disease Risk. Returning for another year, the 3rd Microbiome Movement – Maternal & Infant Health Summit will unite industry and academics in the exploration of preventative and therapeutic treatment of the microbiome during pregnancy and early life.

article thumbnail

Tiny population of neurons may have big role in depression

Scienmag

Credit: Phil Jones, freelance photographer A tiny population of neurons known to be important to appetite appear to also have a significant role in depression that results from unpredictable, chronic stress, scientists say. These AgRP neurons reside exclusively in the bottom portion of the hypothalamus called the arcuate nucleus, or ARC, and are known to […].

article thumbnail

How to Handle Time Off When You Work from Home and Can’t Travel

BioSpace

It’s easy to feel guilty about taking time off when you’re working from home and not physically going on vacation. But your brain needs that vacation.

101
101
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

How messenger substances influence individual decision-making

Scienmag

Psychology: publication in Nature Communications Credit: HHU / Luca Franziska Kaiser As indicated by other studies, different parts of the brain are responsible for different types of decisions. A research team led by Luca Franziska Kaiser and Prof. Dr. Gerhard Jocham from the HHU working group ‘Biological Psychology of Decision Making’, and Dr.

article thumbnail

COVID-19 Vaccine Program Hiccups, Misses and Disasters

BioSpace

There are some big surprises among the list of major players in the vaccine space who either dropped their programs or have been significantly delayed.

article thumbnail

Prestigious Sci-Tech Oscar goes to three former computer science PhD students

Scienmag

Credit: DFKI Three award winners earned their doctorates under Philipp Slusallek at Saarland University. The university professor and DFKI researcher has significantly advanced the award-winning ray tracing technology over the past two decades. Today, this technology provides many Hollywood movies and computer games with the perfect images and can also recently be found in almost […].

Doctors 91
article thumbnail

Innovators investing in new injectable devices to speed vaccination campaigns

BioPharma Reporter

In recent months we have seen companies investing in capacity and technology around pre-fillable systems for both new injectable drugs and vaccines.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

People on the Move: February 2021

Outsourcing Pharma

This monthâs announcements about industry hires, promotions, alliances and other important events includes Merck, Lonza, Medable and other key firms.

article thumbnail

Immunai Gets Series A Funding for Genomics Database Advancements

BioSpace

Immunai today announced it has received $60 million in Series A funding, bringing its total funding since inception in December 2018 to $80 million.

Genome 98
article thumbnail

Adult neurogenesis may hold clues for more effective treatment of alcoholism

Scienmag

New research and analysis examine how alcohol exposure impacts many aspects of neuroplasticity in a special issue of Brain Plasticity Credit: Steven P. Guerin Amsterdam, NL, February 10, 2021 – Neuroplasticity, the remarkable ability of the brain to modify and reorganize itself, is affected by or in response to excessive alcohol, whether through individual consumption […].

article thumbnail

6 Tips for Finding Work During the Coronavirus Pandemic

BioSpace

Let’s review the six tips for finding work during the coronavirus pandemic.

122
122
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.